[ET Net News Agency, 20 August 2021] CSPC PHARMA (01093) fell 2.75% to HK$10.6, dipping
below the 100-D SMA of HK$10.614.
It hits an intra-day low of HK$10.54, and an intra-day high of HK$11.24. The total
shares traded was 8.04 million, with a value of HK$86.78m. The active buy/sell ratio is
43:57, with net selling turnover of HK$10.53m. HUATAI FIN HLDGS HK accounts for greatest
net responsive buying turnover of HK$5.48m, with volume weighted average price of
HK$10.774. CLSA LTD accounts for greatest net responsive selling turnover of HK$4.59m,
with volume weighted average price of HK$10.753. The stock has fallen a combined 5.69%
over the past 3 consecutive trading days.
The Hang Seng Index now fell 292 points, or 1.16% to 25,023; the Hang Seng China
Enterprises Index now fell 104 points, or 1.17% to 8,811; the Hang Seng TECH Index now
fell 98 points, or 1.62% to 5,945; with an overall turnover of HK$32.64b.
The SSE Composite Index now fell 34 points, or 0.99% to 3,431, with an overall turnover
of RMB129.4b.
The SZSE Component Index now fell 152 points, or 1.06% to 14,334, with an overall
turnover of RMB80.97b.
Basic Information
-------------------------------------------
Nominal 10.600 % Chg -2.75%
High 11.240 Low 10.540
Shares Tr 8.04m Turnover 86.78m
10-D SMA 10.962 %H.V 42.998
20-D SMA 10.692 VWAP 10.789
50-D SMA 10.946 RSI14 45.434
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 43:57, with net selling
turnover of HK$10.53m, falling a combined 5.69% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
CSPC PHARMA (01093) 10.60 -2.75
SIHUAN PHARM (00460) 2.15 -4.44
CMS (00867) 16.58 -3.83
SINO BIOPHARM (01177) 6.49 -1.96
3SBIO (01530) 6.97 -5.04
LUYE PHARMA (02186) 3.80 -2.56
FOSUN PHARMA (02196) 51.95 -2.81
WUXI APPTEC (02359) 140.00 -3.51
HANSOH PHARMA (03692) 25.65 -0.58
PHARMARON (03759) 150.50 -4.02
-------------------------------------------------
(ed)